ArticleClinicoEconomics and outcomes research : CEOR2021

Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada.

Stephane Roze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.